Abstract:Effective T cell responses against infections and tumors require a swift and ample production of cytokines, chemokines, and cytotoxic molecules. The production of these effector molecules relies on rapid changes of gene expression, determined by cell-intrinsic signals and environmental cues. Here, we review our current understanding of gene-specific regulatory networks that define the magnitude and timing of cytokine production in CD8 + T cells. We discuss the dynamic features of post-transcriptional control d… Show more
“…The production of inflammatory cytokines such as IFN‐γ is regulated on multiple levels 57‐62 . Besides the well‐characterized transcriptional and epigenetic regulation that is enforced by transcription factor availability and activation status, as well as histone modification, 57,60,63‐65 post‐transcriptional regulatory events play a crucial role to fine‐tune T cell responses 6,16,62,66‐73 .…”
“…TCR triggering results in the engagement of multiple downstream signalling modules, cooperatively engaging the transcriptional, post‐transcriptional and translational machinery in T cells (Figure 1A). Engagement of the PI3K‐AKT, protein kinase C (PKC) and mitogen‐activated protein kinase (MAPK) pathways result in the initiation of mRNA transcription and can influence cytokine mRNA stability, while activation of mTOR is essential for the initiation of cytokine mRNA translation into protein 6,15,62 . Together, the qualitative and quantitative engagement of these distinct pathways determine the cytokine protein output of T cells upon TCR stimulation 6,62 …”
Section: Tcr and Tlr Signalling In T Cellsmentioning
CD8+ T cells are critical to combat pathogens and eradicate malignantly transformed cells. To exert their effector function and kill target cells, T cells produce copious amounts of effector molecules, including the pro‐inflammatory cytokines interferon γ, tumour necrosis factor α and interleukin 2. TCR triggering alone is sufficient to induce cytokine secretion by effector and memory CD8+ T cells. However, T cells can also be directly activated by pathogen‐derived molecules, such as through the triggering of Toll‐like receptors (TLRs). TLR‐mediated pathogen sensing by T cells results in the production of only interferon γ. However, in particular when the antigen load on target cells is low, or when TCR affinity to the antigen is limited, antigen‐experienced T cells can benefit from costimulatory signals. TLR stimulation can also function in a costimulatory fashion to enhance TCR triggering. Combined TCR and TLR triggering enhances the proliferation, memory formation and effector function of T cells, resulting in enhanced production of interferon γ, tumour necrosis factor α and interleukin 2. Therefore, TLR ligands or the exploitation of TLR signalling could provide novel opportunities for immunotherapy approaches. In fact, CD19 CAR T cells bearing an intracellular TLR2 costimulatory domain were recently employed to treat cancer patients in a clinical trial. Here, the current knowledge regarding TLR2/7 stimulation‐induced cytokine production by T cells is reviewed. Specifically, the transcriptional and post‐transcriptional pathways engaged upon TLR2/7 sensing and TLR2/7 signalling are discussed. Finally, the potential uses of TLRs to enhance the anti‐tumor effector function of T cells are explored.
“…The production of inflammatory cytokines such as IFN‐γ is regulated on multiple levels 57‐62 . Besides the well‐characterized transcriptional and epigenetic regulation that is enforced by transcription factor availability and activation status, as well as histone modification, 57,60,63‐65 post‐transcriptional regulatory events play a crucial role to fine‐tune T cell responses 6,16,62,66‐73 .…”
“…TCR triggering results in the engagement of multiple downstream signalling modules, cooperatively engaging the transcriptional, post‐transcriptional and translational machinery in T cells (Figure 1A). Engagement of the PI3K‐AKT, protein kinase C (PKC) and mitogen‐activated protein kinase (MAPK) pathways result in the initiation of mRNA transcription and can influence cytokine mRNA stability, while activation of mTOR is essential for the initiation of cytokine mRNA translation into protein 6,15,62 . Together, the qualitative and quantitative engagement of these distinct pathways determine the cytokine protein output of T cells upon TCR stimulation 6,62 …”
Section: Tcr and Tlr Signalling In T Cellsmentioning
CD8+ T cells are critical to combat pathogens and eradicate malignantly transformed cells. To exert their effector function and kill target cells, T cells produce copious amounts of effector molecules, including the pro‐inflammatory cytokines interferon γ, tumour necrosis factor α and interleukin 2. TCR triggering alone is sufficient to induce cytokine secretion by effector and memory CD8+ T cells. However, T cells can also be directly activated by pathogen‐derived molecules, such as through the triggering of Toll‐like receptors (TLRs). TLR‐mediated pathogen sensing by T cells results in the production of only interferon γ. However, in particular when the antigen load on target cells is low, or when TCR affinity to the antigen is limited, antigen‐experienced T cells can benefit from costimulatory signals. TLR stimulation can also function in a costimulatory fashion to enhance TCR triggering. Combined TCR and TLR triggering enhances the proliferation, memory formation and effector function of T cells, resulting in enhanced production of interferon γ, tumour necrosis factor α and interleukin 2. Therefore, TLR ligands or the exploitation of TLR signalling could provide novel opportunities for immunotherapy approaches. In fact, CD19 CAR T cells bearing an intracellular TLR2 costimulatory domain were recently employed to treat cancer patients in a clinical trial. Here, the current knowledge regarding TLR2/7 stimulation‐induced cytokine production by T cells is reviewed. Specifically, the transcriptional and post‐transcriptional pathways engaged upon TLR2/7 sensing and TLR2/7 signalling are discussed. Finally, the potential uses of TLRs to enhance the anti‐tumor effector function of T cells are explored.
“…Their absence in T cells leads to T cell hyperactivation and autoimmune/inflammatory disease. The ZFP36 family of RBP bind AU-rich elements (AREs) present in the 3' untranslated region (3'UTR) of mRNAs and can effect different outcomes promoting RNA decay 19 , suppressing translation 17,20,21 or directing localised translation 22 which are cell-context-specific 23 .…”
CD8 T cell differentiation into effector cells is initiated early after antigen encounter by signals from the T cell antigen receptor and costimulatory molecules. The molecular mechanisms that determine the timing and rate of differentiation however are not defined. Here we show that the RNA binding proteins (RBP) ZFP36 and ZFP36L1 limit the rate of differentiation of activated naive CD8 T cells and the potency of the resulting cytotoxic lymphocytes. The RBP act in an early and short temporal window to enforce dependency on costimulation via CD28 for full T cell activation and effector differentiation by directly binding mRNA of NF-kB, IRF8 and NOTCH1 transcription factors and IL2. Their absence in T cells, or the adoptive transfer of a small numbers of CD8 T cells lacking the RBP, promotes resilience to influenza A virus infection without immunopathology. These findings highlight ZFP36 and ZFP36L1 as nodes for the integration of the early T cell activation signals determining the speed and quality of the CD8 response.
“…Evidence is accumulating that in addition to transcriptional and metabolic alterations, posttranscriptional and post-translational mechanisms are critical determinants for T cell effector function (Salerno et al, 2020). In activated Jurkat T cells, for instance, as much as 50% of the transcriptome changes was attributed to alterations in mRNA stability (Cheadle et al, 2005).…”
T cell differentiation and activation induces substantial alterations in gene expression. While RNA sequencing and single cell RNA sequencing analysis provided important insights in the gene expression dynamics of T cells, it is not well understood how the mRNA expression translates into the protein landscape. By combining paired RNA-sequencing and mass spectrometry data of primary human CD8 + T cells, we found that mRNA expression is a poor proxy for the overall protein output. Irrespective of the differentiation or activation status, the correlation coefficient of human CD8 + T cells reached a mere 0.41-0.43. Only gene classes that mediate conserved cellular processes such as protein translation or cellular metabolism showed a strong correlation of mRNA with protein expression. In contrast, the mRNA expression and protein output of transcription factors, cell surface molecules, and secreted proteins -including cytokines -only mildly correlated. Conversely, highly conserved genes correlated well with the protein output. This was also true for the presence of AU-rich elements in the 3'untranslated region, in particular for mRNAs that encode secreted proteins.In conclusion, the in-depth characterization of the transcriptome and proteome in human CD8 + T cells emphasizes the need of combined mRNA and protein analysis for our understanding of T cell biology and function.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.